These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 14653429

  • 1. Pharmacologic management of psychosis in the elderly: a critical review.
    Hoeh N, Gyulai L, Weintraub D, Streim J.
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):213-8. PubMed ID: 14653429
    [Abstract] [Full Text] [Related]

  • 2. Atypical antipsychotics in Parkinson-sensitive populations.
    Friedman JH, Fernandez HH.
    J Geriatr Psychiatry Neurol; 2002 Dec; 15(3):156-70. PubMed ID: 12230086
    [Abstract] [Full Text] [Related]

  • 3. Emergency treatment of acute psychosis.
    Hillard JR.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 1():57-60; discussion 61. PubMed ID: 9448670
    [Abstract] [Full Text] [Related]

  • 4. Review of recent clinical studies with olanzapine.
    Tollefson GD, Kuntz AJ.
    Br J Psychiatry Suppl; 1999 Dec; (37):30-5. PubMed ID: 10211139
    [Abstract] [Full Text] [Related]

  • 5. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ, Johnson EG, Johnson HE, Ensom MHH.
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [Abstract] [Full Text] [Related]

  • 6. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T, Cudkowicz ME, Sexton PM, Growdon JH.
    J Neuropsychiatry Clin Neurosci; 2000 Aug; 12(3):364-9. PubMed ID: 10956570
    [Abstract] [Full Text] [Related]

  • 7. Rationale and guidelines for the inpatient treatment of acute psychosis.
    Feifel D.
    J Clin Psychiatry; 2000 Aug; 61 Suppl 14():27-32. PubMed ID: 11154014
    [Abstract] [Full Text] [Related]

  • 8. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    Ghaemi SN.
    J Clin Psychiatry; 2000 Aug; 61 Suppl 14():33-42. PubMed ID: 11154015
    [Abstract] [Full Text] [Related]

  • 9. Antipsychotic agents and bipolar disorder.
    Tohen M, Zarate CA.
    J Clin Psychiatry; 1998 Aug; 59 Suppl 1():38-48; discussion 49. PubMed ID: 9448668
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
    Marsh L, Lyketsos C, Reich SG.
    Psychosomatics; 2001 Aug; 42(6):477-81. PubMed ID: 11815682
    [Abstract] [Full Text] [Related]

  • 11. Management of psychotic aspects of Parkinson's disease.
    Juncos JL.
    J Clin Psychiatry; 1999 Aug; 60 Suppl 8():42-53. PubMed ID: 10335670
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
    Cummings JL, Street J, Masterman D, Clark WS.
    Dement Geriatr Cogn Disord; 2002 Aug; 13(2):67-73. PubMed ID: 11844887
    [Abstract] [Full Text] [Related]

  • 13. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 14. The management of psychosis in movement disorder patients.
    Chou KL, Borek LL, Friedman JH.
    Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539
    [Abstract] [Full Text] [Related]

  • 15. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
    Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA.
    Am J Geriatr Psychiatry; 2001 May; 9(4):346-60. PubMed ID: 11739062
    [Abstract] [Full Text] [Related]

  • 16. Olanzapine and negative symptoms.
    Rosen EH.
    J Clin Psychiatry; 1998 Oct; 59(10):537-8. PubMed ID: 9818636
    [No Abstract] [Full Text] [Related]

  • 17. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [Abstract] [Full Text] [Related]

  • 18. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA.
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [Abstract] [Full Text] [Related]

  • 19. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A.
    J Clin Psychiatry; 2004 Jan; 65 Suppl 11():16-22. PubMed ID: 15264967
    [Abstract] [Full Text] [Related]

  • 20. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR, Mahmoud R.
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.